Within-host evolutionary dynamics of antimicrobial quantitative resistance

Archive ouverte

Djidjou-Demasse, Ramsès | Sofonea, Mircea, T | Choisy, Marc | Alizon, Samuel

Edité par CCSD ; EDP Sciences -

A preprint peer-reviewed and recommended by PCI Mathematical & Computational Biology (https://mcb.peercommunityin.org/). International audience. Antimicrobial efficacy is traditionally described by a single value, the minimal inhibitory concentration (MIC), which is the lowest concentration that prevents visible growth of the bacterial population. As a consequence, bacteria are classically qualitatively categorized as resistant if therapeutic concentrations are below MIC and susceptible otherwise. However, there is a continuity in the space of the bacterial resistance levels. Here, we introduce a model of within-host evolution of resistance under treatment that considers resistance as a continuous quantitative trait, describing the level of resistance of the bacterial population. The use of integro-differential equations allows to simultaneously track the dynamics of the bacterial population size and the evolution of its level of resistance. We analyze this model to characterize the conditions; in terms of (a) the efficiency of the drug measured by the antimicrobial activity relatively to the host immune response, and (b) the cost-benefit of resistance; that (i) prevents bacterial growth to make the patient healthy, and (ii) ensures the emergence of a bacterial population with a minimal level of resistance in case of treatment failure. We investigate how chemotherapy (i.e., drug treatment) impacts bacterial population structure at equilibrium, focusing on the level of evolved resistance by the bacterial population in presence of antimicrobial pressure. We show that this level is explained by the reproduction number R0. We also explore the impact of the initial bacterial population size and their average resistance level on the minimal duration of drug administration in preventing bacterial growth and the emergence of resistant bacterial population.

Suggestions

Du même auteur

Age-structured non-pharmaceutical interventions for optimal control of COVID-19 epidemic

Archive ouverte | Richard, Quentin | CCSD

International audience. In an epidemic, individuals can widely differ in the way they spread the infection, for instance depending on their age or on the number of days they have been infected for. The latter allows...

Optimizing multi-drug strategies to prevent antimicrobial quantitative resistance: A nested within-and between-host model

Archive ouverte | Mann-Manyombe, Martin, L | CCSD

Antimicrobial resistance (AMR) is a critical global challenge driven by the evolution of bacterial populations that reduce the effectiveness of treatments. This study aims to design an optimal antimicrobial deployment strategy tha...

Memory is key in capturing COVID-19 epidemiological dynamics

Archive ouverte | Sofonea, Mircea, T | CCSD

International audience. SARS-CoV-2 virus has spread over the world rapidly creating one of the largest pandemics ever. The absence of immunity, presymptomatic transmission, and the relatively high level of virulence...

Chargement des enrichissements...